ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Neurology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1613558
Acute Ataxia in Children: Etiological Spectrum and Clinical Characteristics
Provisionally accepted- 1Hebei Provincial Children's Hospital, Shijiazhuang, China
- 2The First hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Acute ataxia is one of the most common movement disorders in children, characterized by complex etiologies, some of which may lead to disability or life-threatening complications. Early diagnosis and intervention are therefore crucial. Objective: This study aimed to investigate the etiological spectrum and clinical characteristics of children presenting with acute ataxia as the initial symptom. Methods: A retrospective analysis was conducted on children hospitalized at Hebei Children’s Hospital between January 2018 and December 2024, all of whom exhibited acute ataxia as the primary manifestation. Clinical data, including etiology, age distribution, and laboratory findings, were systematically reviewed and analyzed. Results: A total of 257 children were included, with a male-to-female ratio of 1.14:1 and a median age of onset of 3 years (range: 10 months to 14 years). Initial screening of 315 records identified 58 patients for exclusion. Etiologies varied by age: infants/toddlers (0–3 years) showed acute postinfectious cerebellar ataxia (APCA, 66%), drug intoxication (14%), and acute disseminated encephalomyelitis (ADEM, 8%); preschoolers (4–6 years) had APCA (63%), ADEM (14%), and acute cerebellitis (AC, 8%); school-aged children (7–14 years) presented APCA (48%), AC (21%), and drug intoxication (14%). AC patients exhibited later onset, longer duration from symptom onset to hospital presentation, and more frequent neurological symptoms (encephalopathy, headache, vomiting) compared to APCA. Cerebrospinal fluid (CSF) nucleated cell counts were elevated in AC. Among APCA cases, CSF oligoclonal band (OCB)-positive patients had later onset, extended hospitalization, higher CSF nucleated cell counts, and higher relapse rates. Autoantibody screening in a subset of 135 patients identified CSF OCB, serum myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) immunoglobulin G (IgG), GQ1b, and aquaporin-4 (AQP4) antibodies as common markers. Conclusion: The etiology of acute ataxia in children varies significantly by age, necessitating tailored diagnostic approaches. For cases suggestive of central nervous system demyelination or recurrent ataxia, comprehensive evaluations, including autoantibody testing, tumor screening, and genetic/metabolic assessments, should be considered to guide management and improve outcomes. CSF OCB positivity may identify an APCA subgroup with more pronounced inflammatory features and a potentially higher relapse risk.
Keywords: Acute ataxia, Children, etiology, Autoantibodies, Clinical Characteristics
Received: 17 Apr 2025; Accepted: 10 Sep 2025.
Copyright: © 2025 Zhao, Gao, Wang, Liu, Sun and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Suzhen Sun, sunsuzhb@126.com
Baoguang Li, icke16@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.